{"id":"https://openalex.org/W4362467148","doi":"https://doi.org/10.3389/fpubh.2023.1119652","title":"Improving health evaluations to capture wider value of therapeutics and incentivise innovation","display_name":"Improving health evaluations to capture wider value of therapeutics and incentivise innovation","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362467148","doi":"https://doi.org/10.3389/fpubh.2023.1119652","pmid":"https://pubmed.ncbi.nlm.nih.gov/37064703","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10102525"},"language":"en","primary_location":{"id":"doi:10.3389/fpubh.2023.1119652","doi":"https://doi.org/10.3389/fpubh.2023.1119652","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fpubh.2023.1119652","pdf_url":"https://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/pdf","source":{"id":"https://openalex.org/S2595931848","display_name":"Frontiers in Public Health","issn_l":"2296-2565","issn":["2296-2565"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Public Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113811199","display_name":"Mei Sum Chan","orcid":"https://orcid.org/0000-0002-0230-0571","observed_orcids":["https://orcid.org/0000-0002-0230-0571"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mei Sum Chan","raw_affiliation_strings":["Health Analytics, Lane Clark & Peacock LLP, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Analytics, Lane Clark & Peacock LLP, London, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054758734","display_name":"Jack C. Kowalik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jack C. Kowalik","raw_affiliation_strings":["UK Health & Value, Pfizer Ltd., Tadworth, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UK Health & Value, Pfizer Ltd., Tadworth, United Kingdom","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022193236","display_name":"Tom Ashfield","orcid":"https://orcid.org/0000-0001-8082-3821","observed_orcids":["https://orcid.org/0000-0001-8082-3821"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tom Ashfield","raw_affiliation_strings":["UK Medical Affairs - Anti-infectives, Pfizer Ltd., Tadworth, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UK Medical Affairs - Anti-infectives, Pfizer Ltd., Tadworth, United Kingdom","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050792181","display_name":"Jonathan Pearson\u2010Stuttard","orcid":"https://orcid.org/0000-0003-2175-9975","observed_orcids":["https://orcid.org/0000-0003-2175-9975"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Jonathan Pearson-Stuttard","raw_affiliation_strings":["Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom","Health Analytics, Lane Clark & Peacock LLP, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Health Analytics, Lane Clark & Peacock LLP, London, United Kingdom","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5050792181"],"corresponding_institution_ids":["https://openalex.org/I47508984"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":0.5215,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.68472434,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"11","issue":null,"first_page":"1119652","last_page":"1119652"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12781","display_name":"Global Health Care Issues","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.8960000276565552},{"id":"https://openalex.org/keywords/value-assessment","display_name":"value assessment","score":0.4180000126361847},{"id":"https://openalex.org/keywords/prevention","display_name":"prevention","score":0.492000013589859},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.8140000104904175},{"id":"https://openalex.org/keywords/pandemic","display_name":"pandemic","score":0.9629999995231628},{"id":"https://openalex.org/keywords/insurance-value","display_name":"insurance value","score":0.734000027179718},{"id":"https://openalex.org/keywords/pharmaceutical-innovation","display_name":"pharmaceutical innovation","score":0.5350000262260437},{"id":"https://openalex.org/keywords/innovation-incentives","display_name":"innovation incentives","score":0.45899999141693115}],"concepts":[{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.4775427281856537},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3828372359275818},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.37193650007247925},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.354647159576416},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2881639897823334},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D009936","descriptor_name":"Organizational Innovation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013812","descriptor_name":"Therapeutics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017531","descriptor_name":"Health Care Evaluation Mechanisms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fpubh.2023.1119652","doi":"https://doi.org/10.3389/fpubh.2023.1119652","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fpubh.2023.1119652","pdf_url":"https://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/pdf","source":{"id":"https://openalex.org/S2595931848","display_name":"Frontiers in Public Health","issn_l":"2296-2565","issn":["2296-2565"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Public Health","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10102525","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10102525","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10102525/pdf/fpubh-11-1119652.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Public Health","raw_type":"Text"},{"id":"pmid:37064703","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37064703","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in public health","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:4677c1e2c2fa429cb2532afe0332c3d6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4677c1e2c2fa429cb2532afe0332c3d6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Public Health, Vol 11 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fpubh.2023.1119652","doi":"https://doi.org/10.3389/fpubh.2023.1119652","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fpubh.2023.1119652","pdf_url":"https://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/pdf","source":{"id":"https://openalex.org/S2595931848","display_name":"Frontiers in Public Health","issn_l":"2296-2565","issn":["2296-2565"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Public Health","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362467148.pdf","grobid_xml":"https://content.openalex.org/works/W4362467148.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2745310222","https://openalex.org/W2789154607","https://openalex.org/W2906182659","https://openalex.org/W3048678908","https://openalex.org/W3083484354","https://openalex.org/W3119407584","https://openalex.org/W3128602895","https://openalex.org/W3175063945","https://openalex.org/W4206677002","https://openalex.org/W4316654350","https://openalex.org/W4316813649"],"related_works":["https://openalex.org/W4384661949","https://openalex.org/W1599453314","https://openalex.org/W2214992598","https://openalex.org/W4405605781","https://openalex.org/W4311338540","https://openalex.org/W2026365490","https://openalex.org/W2413197862","https://openalex.org/W7030194789","https://openalex.org/W7097301660","https://openalex.org/W168292269"],"abstract_inverted_index":{"elements":[0],"of":[1],"value,":[2,4],"insurance":[3],"antimicrobial":[5],"resistance,":[6],"pandemics,":[7],"value":[8,16],"assessmentPrevention":[9],"is":[10],"better":[11],"than":[12],"cure-but":[13],"how":[14],"to":[15],"prevention":[17],"and":[18],"incentivise":[19],"investment?":[20]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}